[{"data": {"name": "What Is Measured by Cardiac Fibrosis Biomarkers and Imaging?", "@type": "ScholarlyArticle", "genre": "journal-article", "author": [{"name": "F. Zannad", "@type": "Person"}], "@context": "http://schema.org/", "encoding": [{"@type": "MediaObject", "contentUrl": "https://www.ahajournals.org/doi/pdf/10.1161/CIRCHEARTFAILURE.114.001156", "encodingFormat": "application/pdf"}], "publisher": {"name": "Ovid Technologies (Wolters Kluwer Health)", "@type": "Organization"}, "identifier": [{"@type": "PropertyValue", "value": "10.1161/circheartfailure.114.001156", "propertyID": "DOI"}, {"@type": "PropertyValue", "value": "CCA2HJkB66rcX-CT1j5fzC3duNs-CDe2FcFsN6TQu-CRhpagAbfBar5", "propertyID": "ISCC"}], "datePublished": "2014-03-01"}, "schema": "schema.org", "mediatype": "application/ld+json"}]